AI assistant
OMNICELL, INC. — Director's Dealing 2025
Dec 3, 2025
31980_dirs_2025-12-03_21f26613-1038-4e1a-96e6-b02553119251.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: OMNICELL, INC. (OMCL)
CIK: 0000926326
Period of Report: 2025-12-01
Reporting Person: LIPPS RANDALL A (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-01 | Common Stock | M | 28250 | $27.70 | Acquired | 414898 | Direct |
| 2025-12-01 | Common Stock | S | 28250 | $35.9679 | Disposed | 386648 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-12-01 | Stock Option NQ (Right to Buy) | $27.70 | M | 28250 | Disposed | 2026-02-04 | Common Stock (28250) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 355861 | Indirect |
| Common Stock | 8051 | Indirect |
Footnotes
F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.
F2: The price reported in Column 4 is a weighted average price of $35.9679. The sold price range between $35.65 to $36.4746. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: Shares held in trust with Mr. Lipps' wife.
F4: Shares held in trust for the benefit of Mr. Lipps' children.
F5: The options were granted on 2/4/2016 with 25% vested on the one-year anniversary of the grant date and the reaming amount vesting ratably over a 36 month period. The options were fully vested on 2/4/2020.